Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Sources Sought opportunity from Department Of Defense was posted on June 2, 2022. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

CFO 3.0 Transformation Initiative

Closed
HT0038-22-R-XXXXFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

NAICS

921130 - Public Finance Activities

Place of Performance

VA

Set-Aside

NONE

Documents

1

RFI+CFO.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

Sources Sought

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
Contacts1 person available
OfficeROSSLYN, VA, 22209, USA
Office AddressROSSLYN, VA, 22209, USA
Contacts

Full Description

Show more
The Program Executive Office (PEO) - Defense Health Management System's (DHMS) Chief Financial Office (CFO) is seeking information on contractor interest in providing innovative and transformational business strategies to align the CFO office with broader PEO-DHMS strategy. The CFO seeks to transform into a world-class financial office that integrates and operationalizes the best practices of Government and leading information technology companies. The CFO seeks innovative solutions to problems in the following areas: Consolidation and integration of financial planning and analysis (FP&A), budget management, and budget execution support within the CFO office to maintain efficient, effective fiscal stewardship, making every dollar count PEO DHMS lacks access to timely financial information to support decision making across the acquisition process (portfolio and product planning, relationship development, execution) Financial controls are not consistently applied across the portfolio to ensure efficient, standard compliance with FISCAM requirements Financial data is considered company proprietary (Trade Secrets Act), but access to those data is required across the CFO functions The CFO is contemplating the award of an Other Transaction Authority Agreement in accordance with 10 USC - 4022. The CFO is seeking responses from non-traditional defense contractors as defined as an entity that is not currently performing and has not performed, for at least the one-year period preceding the solicitation of sources by the Department of Defense for the procurement or transaction, any contract or subcontract for the Department of Defense that is subject to full coverage under the cost accounting standards prescribed pursuant to section 1502 of title 41 and the regulations implementing such section (10 USC - 3014). Questions and feedback are encouraged throughout this acquisition process. Anticipated Award: The solicitation for this effort may result in single or multiple awards. The resulting contract may be an Other Transaction Authority Agreement if market research supports that strategy. Request for Information Response Email: j.r.oliver.civ@mail.mil

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

NAICS: 811210
New
Federal
Zeiss Meditec Ophthalmology Equipment Maintenance
Solicitation # HT940627QE003
Solicitation HT940627QE003 is a Request for Quote issued by the Defense Health Agency, Healthcare Contracting Division-Southeast, for a firm-fixed-price contract to provide full-service maintenance for Zeiss MediTec ophthalmology equipment at the Naval Medical Center Camp Lejeune in North Carolina. The scope of work includes regularly scheduled preventative maintenance, timely onsite repairs, and software updates for specific devices, including the CIRRUS 5000, IOLMASTER 700, HFA3 B60, and ATLAS 900. All services must be performed according to manufacturer recommendations and applicable FDA regulations. The contract consists of a base period from December 1, 2026, to November 30, 2027, with four subsequent option periods extending the potential performance through November 30, 2031. This procurement is a total small business set-aside under NAICS code 811210. Award will be made based on the Lowest Priced Technically Acceptable (LPTA) basis, where technical capability is evaluated independently of price. Offerors must submit two separate volumes: Volume I for technical capability, which must describe the functional approach and methodology without identifying company names or logos, and Volume II for comprehensive pricing. Quotes are due by 8:00 am Eastern Time on October 29, 2026. Payment and invoicing will be processed electronically through the Wide Area WorkFlow system.
Electronic and Precision Equipment Repair and Maintenance

POSTED

1 day ago

DEADLINE

in 9 days
View Details
NAICS: 541715
New
Federal
Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Solicitation # HT9427-26-R-E020
The Defense Health Agency Contracting Activity is seeking a single award for the development of a Battlefield Wound Infection Prevention and Treatment Barrier Combination prototype. This product must integrate a physical wound barrier with antimicrobial and antifungal properties to prevent the spread of organisms and systemic infections in combat scenarios. The project aims to advance technologies from a preferred Technology Readiness Level of 5 or higher to a final state of TRL 7 or 8, culminating in mandatory U.S. Food and Drug Administration approval or clearance. The scope of work includes preclinical testing, human clinical trials, and the submission of regulatory packages such as New Drug Applications or Premarket Approval Applications. This procurement is conducted under prototype Other Transaction Authority 10 U.S.C. 4022, meaning standard FAR and DFARS regulations do not apply unless expressly referenced. The estimated period of performance is 48 months, divided into three primary objectives: prototype demonstration, clinical studies and regulatory submissions, and final FDA clearance. Proposals are due by November 6, 2026, and must be submitted in three distinct volumes covering technical approach, management capability, and administrative cost and price. To be eligible, offerors must be registered in the System for Award Management and meet specific criteria, such as being a nontraditional defense contractor or a small business.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

1 day ago

DEADLINE

in 17 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS